The development of bone microstructure, metabolism and biomechanics in lumbar vertebra under short-term glucocorticoid exposure

References

• Seibel MJ, Cooper MS, Zhou H. Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives. Lancet Diabetes Endocrinol. 2013;1(1):59–70.
   PubMed Web of Science ®Google Scholar
• Soen S. Glucocorticoid and bone. Clin Calcium. 2014;24(6):829–36.
   PubMedGoogle Scholar
• Zhou M, Li J, Wu J, Yang Y, Zeng X, Lv X, et al. Preventive effects of Polygonum multiflorum on glucocorticoid-induced osteoporosis in rats. Exp Ther Med. 2017;14(3):2445–60.
   PubMed Web of Science ®Google Scholar
• Cui L, Li T, Liu Y, Zhou L, Li P, Xu B, et al. Salvianolic acid B prevents bone loss in prednisone-treated rats through stimulation of osteogenesis and bone marrow angiogenesis. Plos One. 2012;7(4):e34647
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen Y, Zhao H, Zhong L, Wu L, Cui L. Effects of different doses of dexamethasone on bone qualities in rats. Chin J Biomed Eng. 2011;28(4):737–43.
   Google Scholar
• Ogoshi T, Hagino H, Fukata S, Tanishima S, Okano T, Teshima R. Influence of glucocorticoid on bone in 3-, 6-, and 12-month-old rats as determined by bone mass and histomorphometry. MOD Rheumatol. 2008;18(6):552–61.
   PubMed Web of Science ®Google Scholar
• Bayat M, Fridoni M, Nejati H, Mostafavinia A, Salimi M, Ghatrehsamani M, et al. An evaluation of the effect of pulsed wave low-level laser therapy on the biomechanical properties of the vertebral body in two experimental osteoporosis rat models. Lasers Med Sci. 2016;31(2):305–14.
   PubMed Web of Science ®Google Scholar
• Amiche MA, Albaum JM, Tadrous M, Pechlivanoglou P, Levesque LE, Adachi JD, et al. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials. Osteoporos Int. 2016;27(5):1709–18.
   PubMed Web of Science ®Google Scholar
• Harvey NC, Gluer CC, Binkley N, McCloskey EV, Brandi ML, Cooper C, et al. Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone. 2015;78:216–24.
   PubMed Web of Science ®Google Scholar
• Burrows M, Liu D, Moore S, McKay H. Bone microstructure at the distal tibia provides a strength advantage to males in late puberty: an HR-pQCT study. J Bone Miner Res. 2010;25(6):1423–32.
   PubMed Web of Science ®Google Scholar
• Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis JA, Malluche H, et al. Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 2013;28(1):2–17.
   PubMed Web of Science ®Google Scholar
• Krasselt M, Baerwald C. An update on glucocorticoid-induced osteoporosis. Dtsch Med Wochenschr. 2016;141(5):352–7.
   PubMed Web of Science ®Google Scholar
• Yang M, Trettel LB, Adams DJ, Harrison JR, Canalis E, Kream BE. Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation. Bone. 2010;47(3):573–82.
   PubMed Web of Science ®Google Scholar
• Rauch A, Seitz S, Baschant U, Schilling AF, Illing A, Stride B, et al. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metab. 2010;11(6):517–31.
   PubMed Web of Science ®Google Scholar
• Yao W, Dai W, Jiang L, Lay EY, Zhong Z, Ritchie RO, et al. Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength. Osteoporos Int. 2016;27(1):283–94.
   PubMed Web of Science ®Google Scholar
• Zhou DA, Zheng HX, Wang CW, Shi D, Li JJ. Influence of glucocorticoids on the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. BMC Musculoskelet Disord. 2014;15(1):239.
   PubMedGoogle Scholar
• Conaway HH, Henning P, Lie A, Tuckermann J, Lerner UH. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity. Bone. 2016;93:43–54.
   PubMed Web of Science ®Google Scholar
• Xue ST, Guo HF, Liu MJ, Jin J, Ju DH, Liu ZY, et al. Synthesis of a novel class of substituted benzothiophene or benzofuran derivatives as BMP-2 up-regulators and evaluation of the BMP-2-up-regulating effects in vitro and the effects on glucocorticoid-induced osteoporosis in rats. Eur J Med Chem. 2015;96:151–61.
   PubMed Web of Science ®Google Scholar
• He M, Wang J, Wang G, Tian Y, Jiang L, Ren Z, et al. Effect of glucocorticoids on osteoclast function in a mouse model of bone necrosis. Mol Med Rep. 2016;14(2):1054–60.
   PubMed Web of Science ®Google Scholar
• Andreasen CM, Ding M, Overgaard S, Bollen P, Andersen TL. A reversal phase arrest uncoupling the bone formation and resorption contributes to the bone loss in glucocorticoid treated ovariectomised aged sheep. Bone. 2015;75:32–9.
   PubMed Web of Science ®Google Scholar
• Lin S, Huang J, Zheng L, Liu Y, Liu G, Li N, et al. Glucocorticoid-induced osteoporosis in growing rats. Calcif Tissue Int. 2014;95(4):362–73.
   PubMed Web of Science ®Google Scholar
• Kim HJ. New understanding of glucocorticoid action in bone cells. BMB Rep. 2010;43(8):524–9.
   PubMed Web of Science ®Google Scholar
• Teitelbaum SL. Glucocorticoids and the osteoclast. Clin Exp Rheumatol. 2015;33(4 Suppl 92):S37–S9.
   PubMed Web of Science ®Google Scholar
• Cusano NE, Nishiyama KK, Zhang C, Rubin MR, Boutroy S, McMahon DJ, et al. Noninvasive assessment of skeletal microstructure and estimated bone strength in hypoparathyroidism. J Bone Miner Res. 2016;31(2):308–16.
   PubMed Web of Science ®Google Scholar
• Gao J, Gong H, Huang X, Fang J, Zhu D, Fan Y. Relationship between microstructure, material distribution, and mechanical properties of sheep tibia during fracture healing process. Int J Med Sci. 2013;10(11):1560–9.
   PubMed Web of Science ®Google Scholar
• Soen S. The effects of glucocorticoid on bone architecture and strength. Clin Calcium. 2013;23(7):993–9.
   PubMedGoogle Scholar
• Hoiberg MP, Rubin KH, Gram J, Hermann AP, Brixen K, Haugeberg G. Risk factors for osteoporosis and factors related to the use of DXA in Norway. ARCH Osteoporos. 2015;10:16.
   PubMed Web of Science ®Google Scholar
• Fonseca H, Moreira-Goncalves D, Coriolano HJ, Duarte JA. Bone quality: the determinants of bone strength and fragility. SPORTS Med. 2014;44(1):37–53.
   PubMed Web of Science ®Google Scholar
• Briot K, Roux C. Glucocorticoid-induced osteoporosis. RMD Open. 2015;1(1):e000014.
   PubMed Web of Science ®Google Scholar
• Shi J, Wang L, Zhang H, Jie Q, Li X, Shi Q, et al. Glucocorticoids: dose-related effects on osteoclast formation and function via reactive oxygen species and autophagy. Bone. 2015;79:222–32.
   PubMed Web of Science ®Google Scholar